How Many People Are Taking Ozempic in the United States?

Introduction

It seems like you cannot turn on the news or scroll through social media without hearing about “the shot.” For many, the conversation around weight loss has shifted from calorie counting to clinical biology. You might find yourself wondering if everyone you know is suddenly on the same medication. At TrimRx, we believe that understanding the actual data behind these medications helps clear up the confusion and reduces the stigma often associated with medical weight loss. This article covers current usage statistics, who is taking these medications, and how the landscape of metabolic health is changing. We will explore the numbers behind GLP-1 medications—which include semaglutide, the active ingredient in Ozempic®—to help you understand where this health movement is headed.

If you want to understand how online care works before deciding whether treatment may be appropriate, this guide to getting GLP-1 medications online offers additional context.

The Surge of GLP-1 Medications

The number of people using glucagon-like peptide-1 (GLP-1) medications has grown at an incredible rate over the last few years. A GLP-1 is a hormone naturally produced in your body that helps regulate blood sugar and signals your brain that you are full. Medications like Ozempic® and Wegovy® mimic this hormone, which is why they are so effective for both blood sugar management and weight loss.

Recent data from the Kaiser Family Foundation suggests that approximately 12% of adults in the United States report having taken a GLP-1 medication at some point. This number represents a massive shift in how we approach chronic weight management. To put that in perspective, that is roughly one in every eight adults you meet.

Current Usage vs. Lifetime Use

It is important to distinguish between people who have “ever tried” the medication and those currently using it. While 12% of adults report usage, about 6%—or roughly 15 million people—are currently using a prescription. The difference between these two numbers highlights a significant trend: many people start the medication but do not always stay on it long-term.

Growth Over Time

The popularity of these medications did not happen overnight, but the acceleration has been swift. Usage among U.S. adults doubled between 2023 and 2025. This surge was largely driven by the 2021 FDA approval of Wegovy® (a higher-dose version of semaglutide) specifically for chronic weight management. Once the public realized the same active ingredient in a diabetes medication could support significant weight loss, demand skyrocketed.

Key Takeaway: About 1 in 8 American adults have used a GLP-1 medication, but only about half of those are currently active users, indicating a high rate of starting and stopping.

If you are curious whether a prescription program may fit your health history and goals, you can complete a free eligibility assessment.

Who Is Taking These Medications?

The “average” person taking a GLP-1 medication may not be who you expect. While social media often focuses on celebrities or younger influencers, the clinical data shows a different demographic leading the way.

Age Groups and Gender

The highest usage rates are found among adults aged 50 to 64. In this age group, about 22% of individuals report using a GLP-1 drug. This is often because this age range is when many people begin to face the long-term effects of metabolic “wear and tear,” such as Type 2 diabetes or heart disease.

Women are more likely to use these medications than men. Estimates suggest that 15% of women have used a GLP-1 compared to 9% of men. This may be due to women historically being more proactive about seeking weight management support or the specific metabolic challenges women face during perimenopause and menopause.

Health Profiles

Usage is most common among individuals with specific underlying health conditions:

• Type 2 Diabetes: About 45% of adults with this condition report using a GLP-1.
• Heart Disease: Approximately 29% of individuals with known heart conditions are currently using these medications.
• Obesity and Overweight: Around 23% of people who have been told by a provider that they are overweight or have obesity in the last five years are using a GLP-1.

The Medicare Factor

Usage among seniors (ages 65 and older) is significantly lower, hovering around 9%. This is largely due to Medicare’s current policy, which does not cover medications when they are prescribed specifically for weight loss. While Medicare often covers Ozempic® for diabetes, many seniors who would benefit from it for weight management alone find the cost prohibitive.

For another perspective on choosing an online care model, read this overview of finding GLP-1 treatment through telehealth.

Understanding the Medications: Ozempic® and Beyond

When people ask how many people are taking Ozempic®, they are often using that brand name to refer to the entire class of medications. However, it is helpful to understand the specific products available.

Semaglutide

Semaglutide is the active ingredient found in Ozempic® and Wegovy®.

• Ozempic® was FDA-approved in 2017 to treat Type 2 diabetes. It is also used to reduce the risk of major cardiovascular events like heart attacks or strokes in people with diabetes and heart disease.
• Wegovy® contains the same ingredient but is approved specifically for chronic weight management in adults with a certain BMI.

Tirzepatide

Another common medication is tirzepatide, found in Mounjaro® and Zepbound®. While semaglutide targets one hormone (GLP-1), tirzepatide targets two (GLP-1 and GIP). GIP stands for glucose-dependent insulinotropic polypeptide. This dual action may lead to even higher levels of weight loss for some individuals.

Compounded Medications

Because of the massive demand, brand-name medications have frequently been on the FDA shortage list. During these shortages, many people turn to compounded semaglutide or compounded tirzepatide.

Important: Compounded medications are not FDA-approved. However, they are prepared by licensed pharmacists in FDA-registered and inspected compounding pharmacies. These versions allow patients to continue their treatment even when brand-name versions are unavailable at local pharmacies.

Why Do People Stop Taking It?

Despite the effectiveness of these medications, discontinuation rates are high. Research suggests that 50% to 75% of people who start a GLP-1 stop taking it within the first year. Understanding why people stop is key to improving long-term success.

For a closer look at common digestive symptoms and practical considerations, explore this guide to GLP-1 side effects.

Cost and Insurance Coverage

Cost remains the primary barrier. Many insurance plans have “carve-outs” for weight loss, meaning they simply do not cover these drugs unless you have a diagnosis of Type 2 diabetes. About 14% of people who quit the medication do so because they can no longer afford the monthly out-of-pocket costs.

Side Effects

About 13% of users stop because of side effects. Because these medications slow down digestion, they can cause:

• Nausea
• Vomiting
• Constipation
• Diarrhea
• Abdominal cramping

Most of these symptoms are temporary and happen when the dosage increases. However, without a supportive medical team to help manage these issues, many patients find the discomfort too much to handle and quit prematurely.

The “Goal Weight” Misconception

Some people stop because they reach their target weight and believe they no longer need the medication. However, obesity is a chronic condition, much like high blood pressure. Clinical studies show that when people stop the medication without a long-term maintenance plan, they often regain a significant portion of the weight.

Key Takeaway: Successful weight management with GLP-1s requires more than just the medication; it requires a plan for affordability, side-effect management, and long-term maintenance.

If you are considering treatment and want a provider to review your health history, you can take the free assessment quiz.

The Role of Telehealth in Access

The way people access these medications has changed dramatically. While 76% of users still get their prescriptions from a primary care doctor, more people are turning to specialized telehealth platforms.

We designed our platform to bridge the gap between interest and access. At TrimRx, we focus on a telehealth-first model. This means you can complete your health assessment, speak with a licensed provider, and have your medication shipped directly to your door without ever sitting in a waiting room.

For more detail about the online prescription process, read this step-by-step guide to getting a GLP-1 prescription online.

The TrimRx Process

For those interested in a prescription program, the journey typically follows these steps:

Step 1: Complete the Assessment

Fill out a detailed health quiz about your medical history, current weight, and goals. This helps our partner providers determine if you are a candidate for medication.

Step 2: Clinical Review

A licensed healthcare provider reviews your profile. They may order lab work to ensure the medication is safe for your specific body chemistry.

Step 3: Personalized Treatment Plan

If eligible, the provider writes a prescription for a program tailored to you. This includes medications like compounded semaglutide or compounded tirzepatide from our partner pharmacies.

Step 4: Ongoing Support

You receive your medication in the mail and have 24/7 access to our team for questions about dosing or managing side effects.

The Shift in Obesity Treatment

The fact that millions of people are now taking these medications signals a major shift in medicine. For decades, the medical community—and society at large—treated weight as a matter of willpower. The high usage rates of GLP-1s prove that obesity is a complex metabolic disease.

When you take a GLP-1, you are not “taking the easy way out.” You are using a tool to correct a hormonal imbalance that makes losing weight through diet and exercise alone nearly impossible for some people. This shift toward biological treatment is helping millions of people reduce their risk of:

• Heart disease
• Stroke
• Kidney disease
• Certain types of cancer

Bottom line: The massive number of people taking these drugs reflects a growing recognition that metabolic health requires medical intervention, not just lifestyle changes.

How to Optimize Your Experience

If you are among the millions considering or currently taking these medications, how you support your body matters. Medication is the foundation, but what you build on top of it determines your long-term vitality.

Nutrient Support

Because these medications reduce your appetite, you will be eating less. It is vital to ensure that the food you do eat is nutrient-dense. Many people struggle to get enough protein or fiber while on a GLP-1. We offer quick-access supplements like GLP-1 Daily Support to help fill those nutritional gaps and support digestive health.

Managing Side Effects Naturally

Staying hydrated is the most important step in preventing common issues like nausea and constipation. Small, frequent meals are often better tolerated than three large ones. If you find your energy levels dipping, a supplement like our Weight Loss Boost can provide the metabolic support needed to keep you moving.

Consult Your Provider

It is essential to stay in close contact with your healthcare provider. They can adjust your dose or provide strategies to mitigate side effects. Never change your dosing schedule or stop the medication abruptly without professional guidance.

The Future of Metabolic Health

As research continues, we expect the number of people taking these medications to stay high or even increase. New oral versions (pills) are currently in development, which may make the medications even more accessible for those who are hesitant about injections.

Our mission is to ensure that as more people join this movement, they do so with the best possible support. We combine clinical expertise with a transparent, empathetic approach. We want to help you move past the “hype” and into a sustainable, healthier lifestyle.

Conclusion

The data is clear: millions of Americans are turning to GLP-1 medications to reclaim their health. Whether it is to manage Type 2 diabetes or to address chronic obesity, these medications have become a pillar of modern metabolic care. While the numbers are large, every single person in that 12% has a unique story and a unique health profile.

We are committed to helping you navigate this journey with a personalized program that fits your life. Sustainable weight loss is about more than a number on a scale; it is about how you feel every day. If you are ready to see if a medically supervised program is right for you, the next step is simple.

Take the first step toward a healthier you by taking our free health assessment quiz today.

FAQ

How many people in the U.S. are currently using Ozempic?

While it is difficult to isolate one specific brand, approximately 6% of U.S. adults—about 15 million people—are currently using a GLP-1 medication like Ozempic® or Wegovy®. About 12% of adults report having used one of these medications at some point in their lives.

Is Ozempic approved for weight loss?

Ozempic® is FDA-approved specifically for the treatment of Type 2 diabetes and the reduction of cardiovascular risk in certain patients. However, its active ingredient, semaglutide, is also the active ingredient in Wegovy®, which is FDA-approved for chronic weight management. Many doctors prescribe these medications off-label for weight loss based on their clinical judgment.

Why are so many people stopping their GLP-1 treatment?

Research indicates that 50% to 75% of users stop within the first year, primarily due to the high cost of the medication and insurance coverage gaps. Other common reasons include side effects like nausea and constipation or the mistaken belief that the medication is no longer needed once a goal weight is reached. This side-effect management resource provides additional information about symptoms and treatment support.

Can I get these medications through telehealth?

Yes, many people now access GLP-1 medications through telehealth platforms. These services provide a convenient way to consult with licensed providers, undergo necessary health screenings, and receive prescriptions for medications, including compounded versions from registered pharmacies, which can then be shipped directly to your home. If you are ready to explore whether you may be eligible, you can complete a free assessment quiz.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.